mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.2 |
mRNA |
SGX-523 |
CTRPv2 |
pan-cancer |
AAC |
0.047 |
0.2 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.045 |
0.2 |
mRNA |
CAY10603 |
GDSC1000 |
pan-cancer |
AAC |
0.038 |
0.2 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.2 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.043 |
0.2 |
mRNA |
AZD8055 |
GDSC1000 |
pan-cancer |
AAC |
-0.042 |
0.2 |
mRNA |
compound 1B |
CTRPv2 |
pan-cancer |
AAC |
0.048 |
0.2 |
mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.2 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.2 |